首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備拋棄式

北美預充式注射器市場預測至 2030 年 - 區域分析 - 按類型、材料、設計、應用和配銷通路

市場調查報告書

商品編碼

1494471

北美預充式注射器市場預測至 2030 年 - 區域分析 - 按類型、材料、設計、應用和配銷通路

North America Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type, Material, Design, Application, and Distribution Channel

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 96 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美預灌封注射器市值29.9269億美元，預計2030年將達到67.8362億美元；預計2022年至2030年複合年成長率為10.8%。

慢性病盛行率的增加推動了北美預充式注射器市場

人口老化的加劇以及社會行為和生活方式的變化導致了一些常見的長期健康狀況。根據世界衛生組織 (WHO) 的預測，到 2026 年底，慢性生活方式疾病的盛行率預計將增加 57%。隨著都市化進程的不斷加快，人們更傾向於久坐的生活方式，進而導致類風濕性關節炎、糖尿病等疾病的發生。糖尿病是21世紀全球主要健康問題之一。根據國際糖尿病聯盟（IDF）的數據，2019年北美糖尿病患者人數約為4600萬，預計到2045年將達到6200萬。

其他慢性病，如克隆氏症、多發性硬化症和心血管疾病，則需要頻繁給藥以進行疾病管理和治療。根據世界衛生組織的數據，心血管疾病是死亡的主要原因——每年有近 1,790 萬人因心血管疾病死亡。它已成為全球大量患者群體注射給藥的新標準。此外，這些預充式注射器只需很少的培訓即可供大量患者使用，並且不需要醫療保健專業人員的持續幫助，因此預充式注射器主要在專業醫療保健環境以及家庭醫療保健環境中採用，從而推動了預充式注射器的發展市場成長。

北美預充式注射器市場概況

北美預充式注射器市場分為美國、加拿大和墨西哥。該地區預充式注射器市場的成長主要是由於該地區自注射注射器的採用增加以及用於治療慢性疾病的家庭醫療保健的激增。

根據糖尿病研究所的數據，2022 年美國糖尿病患者人數約為 3,730 萬人（佔人口的 11.3%）。此外，美國每年診斷出約 140 萬個糖尿病病例。根據美國疾病管制與預防中心的數據，2020 年，約 8,800 萬成年人患有糖尿病前期，占美國成年人口的 34.5%。據耶魯大學研究人員稱，到 2022 年，美國約有 3,000 萬人患有糖尿病，其中約 700 萬人需要每日注射胰島素。

美國對不孕症治療的需求不斷增加。據 CDC 稱，到 2022 年，約 22% 的已婚夫婦（其中女性年齡超過 30 歲）在懷第一個孩子方面存在問題。為了克服不孕問題，市面上可以透過預充式注射器進行各種治療。 2023 年7 月，費森尤斯·卡比(Fresenius Kabi) 推出了醋酸加尼瑞克注射液(Ganirelix Acetate Injection)，這是一種仿製生育藥物，採用250 mcg0.5 ml 預裝注射器包裝，作為公司在女性健康領域擴張的一部分。因此，糖尿病和其他疾病的盛行率不斷上升，以及產品推出的激增，預計將推動美國預充式注射器市場的成長。

北美預充式注射器市場收入及 2030 年預測（百萬美元）

北美預充式注射器市場細分

北美預充式注射器市場根據類型、材料、設計、應用、配銷通路和國家進行細分。

根據類型，北美預灌封注射器市場分為一次性預灌封注射器和可重複使用預灌封注射器。 2022 年，一次性預灌封注射器細分市場將佔據更大的北美預灌封注射器市場。

根據材料，北美預灌封注射器市場分為玻璃預灌封注射器和塑膠預灌封注射器。 2022 年，玻璃預灌封注射器細分市場在北美預灌封注射器市場中佔有較大佔有率。

根據設計，北美預灌封注射器市場分為單間和多室。 2022 年，單室細分市場在北美預充式注射器市場中佔據更大佔有率。

從應用來看，北美預灌封注射器市場細分為癌症、糖尿病、自體免疫疾病、傳染病等。到 2022 年，其他細分市場將佔據北美預充式注射器最大佔有率。

依配銷通路，北美預充式注射器市場分為醫院藥局、零售藥局和線上通路。 2022 年，醫院藥局部門佔據北美預灌封注射器市場最大佔有率。

依國家分類，北美預灌封注射器市場分為美國、加拿大和墨西哥。 2022年，美國在北美預充式注射器市場佔據主導地位。

B Braun SE、山東威高集團醫用聚合物有限公司、Gerresheimer AG、Schott AG、Nipro Corp、Becton Dickinson and Co、Baxter International Inc、Terumo Corp 和 Ypsomed Holding AG 是北美預充式注射器領域的一些領先公司市場注射器領域的一些領先公司市場注射器。

The growing aging population and changes in social behavior and lifestyle contribute to some of the common long-term health conditions. As per the World Health Organization (WHO), the prevalence of chronic lifestyle diseases is expected to increase by 57% by the end of 2026. The emerging markets will be hit hardest, as a population explosion is expected in developing countries. With the increasing urbanization, people are more inclined toward a sedentary lifestyle, which results in rheumatoid arthritis, diabetes, and others. Diabetes is one of the major global health issues of the 21st century. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was about 46 million in 2019 and is projected to reach 62 million by 2045. The increase in disease prevalence is approximated to be 35% during the projection period.

Other chronic conditions such as Crohn's disease, multiple sclerosis, and cardiovascular disorders require frequent drug administration for disease management and treatment. As per the WHO, cardiovascular disorders are the leading cause of death-nearly 17.9 million deaths are reported every year due to cardiovascular disorders. It has become a new standard for injectable drug delivery among large patient populations globally. Moreover, these prefilled syringes can be used by a large patient population with minimal training and do not require constant assistance from healthcare professionals, owing to which prefilled syringes are adopted largely in professional healthcare environments as well as home healthcare settings, thereby driving the prefilled syringes market growth.

North America Prefilled Syringe Market Overview

The North America prefilled syringes market is segmented into the US, Canada, and Mexico. The growth of the prefilled syringes market in the region is mainly due to the increased adoption of self-injecting parenteral devices and a surge in home healthcare to treat chronic diseases in the region.

According to the Diabetes Research Institute, the number of people with diabetes in the US was ~37.3 million (11.3% of the population) in 2022. Nearly 28.7 million people in the US were diagnosed with diabetes, and approximately 8.6 million people have undiagnosed diabetes. Further, ~1.4 million diabetes cases are diagnosed each year in the US. According to the Centers for Disease Control and Prevention, in 2020, ~88 million adults had prediabetes, which is 34.5% of the US adult population. According to Yale researchers, in 2022, ~30 million people in the US have diabetes, and about 7 million require daily insulin.

There is an increase in the demand for infertility treatment in the US. According to the CDC, in 2022, ~22% married couples, with women aged above 30 years, have problems in conceiving their first child. To overcome with infertility issues, various treatments are available in the market through prefilled syringes. In July 2023, Fresenius Kabi launched Ganirelix Acetate Injection, a generic fertility drug, in 250 mcg0.5 ml prefilled syringes as part of the company's expansion in women's health. Therefore, the increasing prevalence of diabetes and other disorders, along with surge in product launches, is expected to drive the growth of prefilled syringes market in the US.

North America Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)

North America Prefilled Syringe Market Segmentation

The North America prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.

Based on type, the North America prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger North America prefilled syringe market share in 2022.

Based on material, the North America prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger North America prefilled syringe share in 2022.

Based on designs, the North America prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger North America prefilled syringe share in 2022.

In terms of application, the North America prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest North America prefilled syringe share in 2022.

By distribution channel, the North America prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest North America prefilled syringe market share in 2022.

Based on country, the North America prefilled syringe market is categorized into the US, Canada, and Mexico. The US dominated the North America prefilled syringe market in 2022.

B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Gerresheimer AG, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the North America prefilled syringe market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Prefilled Syringe Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Chronic Disorders
- 4.1.2 Growing Adoption of Self-Injecting Parenteral Devices
4.2 Market Restraints
- 4.2.1 Increasing Product Recalls
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Ongoing Innovation in Prefilled Syringes
4.5 Impact Analysis

5. Prefilled Syringe Market - North America Market Analysis

5.1 North America Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030

6. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 North America Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Disposable Prefilled Syringes
- 6.3.1 Overview
- 6.3.2 Disposable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Reusable Prefilled Syringes
- 6.4.1 Overview
- 6.4.2 Reusable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Material

7.1 Overview
7.2 North America Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
7.3 Glass Prefilled Syringes
- 7.3.1 Overview
- 7.3.2 Glass Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Plastic Prefilled Syringes
- 7.4.1 Overview
- 7.4.2 Plastic Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Design

8.1 Overview
8.2 North America Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
8.3 Single Chamber
- 8.3.1 Overview
- 8.3.2 Single Chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Multi-chamber
- 8.4.1 Overview
- 8.4.2 Multi-chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Application

9.1 Overview
9.2 North America Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Cancer
- 9.3.1 Overview
- 9.3.2 Cancer: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
- 9.4.1 Overview
- 9.4.2 Diabetes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Autoimmune Diseases
- 9.5.1 Overview
- 9.5.2 Autoimmune Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Infectious Diseases
- 9.6.1 Overview
- 9.6.2 Infectious Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Prefilled Syringe Market - Revenue and Forecast to 2030 - by Distribution Channel

10.1 Overview
10.2 North America Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
10.3 Hospital Pharmacies
- 10.3.1 Overview
- 10.3.2 Hospital Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Retail Pharmacies
- 10.4.1 Overview
- 10.4.2 Retail Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Online Channels
- 10.5.1 Overview
- 10.5.2 Online Channels: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Prefilled Syringe Market - Country Analysis

11.1 North America Prefilled Syringes Market, Revenue and Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America Prefilled Syringes Market, by Country
  - 11.1.2.1 US
    - 11.1.2.1.1 US Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.1.2 US: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.1.3 US: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.2.1.4 US: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.2.1.5 US: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.2.1.6 US: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.2.2 Canada
    - 11.1.2.2.1 Overview
    - 11.1.2.2.2 Canada Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.2.3 Canada: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.2.4 Canada: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.2.2.5 Canada: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.2.2.6 Canada: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.2.2.7 Canada: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 11.1.2.3 Mexico
    - 11.1.2.3.1 Overview
    - 11.1.2.3.2 Mexico Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.3.3 Mexico: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.3.4 Mexico: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
    - 11.1.2.3.5 Mexico: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
    - 11.1.2.3.6 Mexico: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
    - 11.1.2.3.7 Mexico: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 Organic Developments
- 12.2.1 Overview
12.3 Inorganic Developments
- 12.3.1 Overview

13. Company Profiles

13.1 B Braun SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Shandong Weigao Group Medical Polymer Co Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Gerresheimer AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Schott AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Nipro Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Becton Dickinson and Co
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Baxter International Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Terumo Corp
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Ypsomed Holding AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Prefilled Syringe Market Segmentation
Table 2. US Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. US Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Prefilled Syringe Market

List Of Figures

Figure 1. North America Prefilled Syringe Market Segmentation, By Country
Figure 2. North America Prefilled Syringe Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Disposable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Reusable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. North America Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
Figure 9. Glass Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Plastic Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
Figure 12. Single Chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Multi-chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. North America Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cancer: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Autoimmune Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 21. Hospital Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Online Channels: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: Prefilled Syringes Market, by Key Country - Revenue (2022) (US$ Million)
Figure 25. North America Prefilled Syringes Market, By Key Countries, 2022 and 2030 (%)
Figure 26. US Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Canada Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Mexico Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)